Penn researcher wins awards from two major cardiovascular research organizations

November 14, 2005

Shiriki Kumanyika, PhD, MPH, a Professor in the Department of Biostatistics and Epidemiology at the University of Pennsylvania School of Medicine, has won the first-ever American Heart Association Population Research Prize. She received the prestigious national distinction for her continued tireless efforts in a career devoted to the prevention of heart disease, stroke and related disorders.

The new award was presented to Kumanyika today (November 13th) at the annual Scientific Sessions of the AHA in Dallas, Texas. This award is to recognize and reward an individual who is making outstanding contributions to the advancement of cardiovascular science and who currently heads an outstanding cardiovascular population research laboratory. The prize consists of a citation and an honorarium of $5,000.

Additionally, Kumanyika received the 2005 Dr. Herbert W. Nickens Epidemiology Award from the Association of Black Cardiologists, Inc (ABC). She was honored during a luncheon associated with the ABC Congress on Saturday, November 12th, also in Dallas, Texas. This award was created to honor outstanding achievement in epidemiologic research in the area of cardiovascular disease.

Kumanyika, who is the Associate Dean for Health Promotion and Disease Prevention at the University of Pennsylvania School of Medicine, has trained a generation of scientists and devoted her life to the prevention of heart disease and stroke. Her research focuses on the role of nutritional factors in the primary and secondary prevention of chronic diseases, with a particular focus on obesity, sodium reduction and related health problems such as hypertension and diabetes.

She has been the principal investigator or co-investigator of major randomized clinical trials of dietary changes in modifying cardiovascular risk factors. Her studies involve developing and evaluating culturally appropriate interventions to prevent or treat obesity among African-Americans in clinical or community settings.

"I see the creation of this (AHA Population Research) prize as both a coming of age and a challenge for population-oriented research to fight heart disease and stroke," comments Kumanyika. "This award is a coming of age because it puts an ultimate finishing touch on the AHA's commitment to see population science as a critical dimension in the bigger picture of cardiovascular research. It is a challenge because of the bigger picture. Population research addresses the impossible to control, difficult to modify, socially fluctuating and all too political reality that determines: who develops heart disease and stroke; whose risks are identified early versus late; who is treated; and who is ultimately able to achieve the potential for longevity and high quality of life."

Kumanyika further adds, "The disparities in cardiovascular disease are so vivid and so longstanding that, we know, unfortunately, almost without having to count, that African Americans for example, or people with low incomes will have more heart disease and stroke and be more likely to die from it. I look forward to the day when the recipient of this award can say that we have remedied this situation."

Kumanyika has a unique interdisciplinary background that integrates epidemiology, nutrition, prevention, minority health, aging, and women's health issues. A native of Baltimore, Maryland, she holds a B.A. from Syracuse University, Master of Science in Social Work from Columbia University, Ph.D. in Human Nutrition from Cornell University, and Master of Public Health from the Johns Hopkins University School of Public Health.

She has served the American Heart Association in many roles over the last two decades, including as a spokesperson on diet and related health issues, as chair of the Council on Epidemiology and Prevention, and as a member of the national Board of Directors.
-end-
Editor's Note:

For more information on Dr. Shiriki Kumanyika, go on-line to: http://www.cceb.med.upenn.edu/main/people/kumanyika.html

PENN Medicine is a $2.7 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.

Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #4 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

The University of Pennsylvania Health System includes three hospitals [Hospital of the University of Pennsylvania, which is consistently ranked one of the nation's few "Honor Roll" hospitals by U.S. News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center]; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.

University of Pennsylvania School of Medicine

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.